Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Download your interactive eBook
Vital updates and insights into the increasingly important area of gene therapy. Stay current with the latest gene therapy developments as reported in Pink Sheet, In Vivo and Scrip. Topics in your free, interactive eBook include:
Pink Sheet: global policy and regulatory coverage
By Vibha Sharma 28 Sep 2020
A draft EU guideline explains how disease registries can be used to supplement evidence in the pre-authorization phase and provide...
Pink Sheet: global policy and regulatory coverage
28 Sep 2020
Drug companies have their last chance to negotiate which documents and information Italy’s regulator, AIFA, will be entitled to request...
Pink Sheet: global policy and regulatory coverage
By Ian Schofield 28 Sep 2020
As the final scheduled round of post-Brexit trade talks begins amid growing concern over the prospect of a deal and...
Request a Trial
Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.
How can we help you?
Our team is always happy to hear from you. Please call us at:
Pharma Report Store
Have an immediate and specific information need?
Browse and buy from 1000s of analysis and research reports now:
Biomedtracker provides real-time analysis of major market-moving events in the pharma and biotech industries. With catalyst tracking and expert insights, Biomedtracker helps you stay on top of breaking events, the drugs pipeline, upcoming milestones, companies, and deals – and their impact on the markets you care about.
A well-respected and trusted industry source for the last 15 years, Generics Bulletin from Informa Pharma Intelligence provides in-depth news and analysis on issues that matter most to businesses across the generics, biosimilars and value-added medicines industries.
HBW Insight is a single source of regulatory, legislative, legal and commercial news and insight connecting the dots across 3 sectors, including over the counter medicines, vitamins and dietary supplements, and cosmetics, which have increasing points of intersection, helping you to anticipate global challenges, risks, and opportunities.
Looking for more products Product Finder
